Immunology of VIP: A Review and Therapeutical Perspectives
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
89-111
Author(s):
R.P. Gomariz, C. Martinez, C. Abad, J. Leceta and M. Delgado
Nerve Growth Factor in Neurological and Non-Neurological Diseases: Basic Findings and Emerging Pharmacological Prospectives
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
113-123
Author(s):
Luigi Aloe, Paola Tirassa and Luisa Bracci-Laudiero
The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Journal:
Current Drug Targets
Volume:
1
Page:
327-364
Author(s):
M. Gardnerova, R. Blanque and C. R. Gardner
Role of Cyclooxygenases in Angiogenesis
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1163-1170
Author(s):
K. M. Leahy, A. T. Koki and J. L. Masferrer
Clinical Experience with Specific COX-2 Inhibitors in Arthritis
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1725-1736
Author(s):
Leslie J. Crofford
Docosahexaenoic Acid and Membrane Lipid Domains
Journal:
Current Organic Chemistry
Volume:
4
Page:
1169-1183
Author(s):
William Stillwell
Biologic Agents in the Treatment of Rheumatoid Arthritis
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
217-233
Author(s):
Boulos Haraoui, Vibeke Strand and Edward Keystone
Inhibitors of the Enzyme Purine Nucleoside Phosphorylase as Potential Therapy for Psoriasis
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
943-959
Author(s):
Philip E. Morris,Jr. and George A. Omura
Withdrawn: Effects of Tofacitinib on Tfr/Tfh Balance and Expression of CXCL13 and TGF-β1 in Experimental Autoimmune Encephalomyelitis Rats
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
17
Page:
604-611
Author(s):